PMMCT1-Clinical therapeutics 1

Module Provider: Pharmacy
Number of credits: 60 [30 ECTS credits]
Level:7
Terms in which taught: Spring / Summer term module
Pre-requisites:
Non-modular pre-requisites:
Co-requisites:
Modules excluded:
Current from: 2022/3

Module Convenor: Miss Kate Fletcher
Email: k.e.fletcher@reading.ac.uk

Type of module:

Summary module description:

This module aims to provide a systems-based approach to clinical therapeutics, including pharmacology, pharmacokinetics, treatment, monitoring and person-centred care considerations to deliver effective clinical pharmacy practice.Ìý Students will undertake 50% of the module as experiential learning to embed communication, consultation and medicines optimisation knowledge, skills and behaviours.Ìý Students will be supported to reflect on their experiences by developing a professional portfolio of experiential learning which will be used throughout the MSc programme.Ìý This module will be studied at the °ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼ and within local clinical pharmacy healthcare providers.

Aims:

This module aims to provide a systems-based approach to clinical therapeutics, including pharmacology, pharmacokinetics, treatment, monitoring and person-centred care considerations to deliver effective clinical pharmacy practice.Ìý Students will undertake 50% of the module as experiential learning to embed communication, consultation and medicines optimisation knowledge, skills and behaviours.

Ìý

Assessable learning outcomes:

Knowledge:

1. Discuss the aetiology, epidemiology, diagnosis, treatment and monitoring for the stated disease states


2. Describe the role healthcare practitioners can take in providing pharmaceutical care for patients with the stated disease states


3. Understand the non-medicine treatment and advice that can be used to improve patients’ quality of life with the stated disease states


4. Describe how evidence-based medicine supports decision making for the stated disease states

Ìý

Skills

1. Critically appraise literature to formulate treatment recommendations for individual patient cases


2. Demonstrate safe and effective communication skills with patients and other healthcare professionals


3. Demonstrate ability to prioritise and justify treatment recommendations


4. Demonstrate ability to suggest counselling and medicine information recommendations to improve medicines optimisation


5. Demonstrate oral presentation skills to peers

Ìý

Behaviours

1. Demonstrate a willingness to communicate effectively with patients and other healthcare professionals in a non-discriminatory manner


2. Demonstrate a proactive attitude to learning opportunities and working as part of a team


3. Demonstrate a reflective approach to case presentations, collaboratively supporting peers and receiving constructive criticism openly


4. Recognise own limitations and escalate concerns regarding a patient’s care to the appropriate named individual in a timely manner

Additional outcomes:

Outline content:

This module will focus on embedding clinical therapeutics knowledge within experiential learning.Ìý A systems-based approach will be utilised to cover core topics such as cardiology, respiratory, endocrinology, surgery, infections, laboratory tests, neurology and gastroenterology.

Global context:

This module will highlight the differences in international healthcare practice, supporting students to consider the International Pharmaceutical Federation’s Global Competency Framework in their local context.

Ìý

Brief description of teaching and learning methods:

This module will use a range of teaching and learning methods including face to face lectures, workshops and tutorials.Ìý In addition, there will be simulated learning to support communication skills development.Ìý The remaining 50% of the time will be experiential learning, embedded in local healthcare providers, observing healthcare practice, researching pharmaceutical care plans and then reflecting on these patient cases with tutors, peers and/or other clinicians.

Contact hours:

Ìý	Autumn	Spring	Summer
Lectures		30	30
Seminars		60	60
Work-based learning		100	75
Guided independent study:	Ìý	Ìý	Ìý
Ìý Ìý Wider reading (independent)		20	25
Ìý Ìý Completion of formative assessment tasks		40	40
Ìý Ìý Group study tasks		20	20
Ìý Ìý Reflection		40	40
Ìý	Ìý	Ìý	Ìý
Total hours by term	0	310	290
Ìý	Ìý	Ìý	Ìý
Total hours for module	600

Summative Assessment Methods:

Method	Percentage
Written assignment including essay	30
Portfolio	50
Oral assessment and presentation	20

Summative assessment- Examinations:

1. Oral presentation of one pharmaceutical care plan

Summative assessment- Coursework and in-class tests:

1. One written pharmaceutical care plan


2. Experiential learning portfolio

Formative assessment methods:

1. Presentation of pharmaceutical care plans prior to inclusion in experiential learning portfolio


2. Workplace-based assessments during experiential learning

Penalties for late submission:

The below information applies to students on taught programmes except those on Postgraduate Flexible programmes. Penalties for late submission, and the associated procedures, which apply to Postgraduate Flexible programmes are specified in the policy £Penalties for late submission for Postgraduate Flexible programmes£, which can be found here: /cqsd/-/media/project/functions/cqsd/documents/cqsd-old-site-documents/penaltiesforlatesubmissionpgflexible.pdf
The Support Centres will apply the following penalties for work submitted late:

• where the piece of work is submitted after the original deadline (or any formally agreed extension to the deadline): 10% of the total marks available for that piece of work will be deducted from the mark for each working day (or part thereof) following the deadline up to a total of five working days;
• where the piece of work is submitted more than five working days after the original deadline (or any formally agreed extension to the deadline): a mark of zero will be recorded.

The University policy statement on penalties for late submission can be found at: /cqsd/-/media/project/functions/cqsd/documents/cqsd-old-site-documents/penaltiesforlatesubmission.pdf
You are strongly advised to ensure that coursework is submitted by the relevant deadline. You should note that it is advisable to submit work in an unfinished state rather than to fail to submit any work.

Assessment requirements for a pass:

1. The oral presentation and written pharmaceutical care plan must be passed at 50% with all essential criteria met


2. The experiential learning portfolio must be passed at 50% and contain all mandatory content

Reassessment arrangements:

Reassessment will be arranged promptly to not delay the next module’s experiential learning component.Ìý Individualised timings may be required depending on the specific requirements for reassessment.

Additional Costs (specified where applicable):

Last updated: 22 September 2022